Stock traders acquired 574 put options on the company. This represents an increase of 496% compared to the average daily volume of 167 call options.
In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, May 3rd. Barclays Capital reinitiated the shares of WBA in report on Thursday, March 10 with "Equal-Weight" rating.
Hedge funds have recently made changes to their positions in the company.
Director, Babiak Janice M., purchased 600 common shares of Walgreens Boots Alliance, Inc. Ubs Asset Mngmt Americas Inc holds 0% of its portfolio in JetBlue Airways Corporation (NASDAQ:JBLU) for 57,725 shares.
While looking at the Stock's Performance, Walgreens Boots Alliance, Inc. now shows a Weekly Performance of -7.5%, where Monthly Performance is -5.99%, Quarterly performance is -7.97%, 6 Months performance is -11.49% and yearly performance percentage is -8.8%.
Investors may be interested in viewing the Gross Margin score on shares of Walgreens Boots Alliance, Inc. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. Company insiders own 13.50% of the company's stock. As of the end of the quarter Baird Financial Group, Inc. had bought 20,896 shares growing its stake by 7.3%. MUFG Americas Holdings Corp now owns 155,729 shares of the pharmacy operator's stock worth $12,889,000 after buying an additional 2,866 shares during the period.More news: Senator: US at risk of military conflict with Russia, Iran in Syria
Walgreens Boots Alliance (NASDAQ WBA) traded down 2.24% on Thursday, reaching $76.37. During the same quarter past year, the company posted $1.31 earnings per share.
Tightening the gaze, stock performance for the last 5 trading days is -7.50%.
09/16/2016 - Walgreens Boots Alliance, Inc. had its "outperform" rating reiterated by analysts at Leerink Swann. WBA's profit will be $1.42B for 14.55 P/E if the $1.32 EPS becomes a reality.
Walgreens Boots Alliance Inc (NASDAQ:WBA) exchanged hands 8.00 Million shares versus average trading capacity of 4.75 Million shares, while its relative trading volume is 1.85. The pharmacy operator reported $1.36 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $1.36. The company's market cap is $86.89 Billion. Looking out over a next 5-year period, analysts expect the company to see its earnings go up by 20.96%, annually. Analysts have a mean recommendation of 2.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).
The business also recently announced a quarterly dividend, which was paid on Monday, June 12th. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.92%. Walgreens Boots Alliance's dividend payout ratio (DPR) is now 38.36%. Jetblue Airways had 24 analyst reports since July 29, 2015 according to SRatingsIntel. S&P Research has "Buy" rating and $99 target. The stock has "Outperform" rating by Credit Suisse on Monday, November 16. Deutsche Bank AG reissued a "buy" rating and set a $92.00 target price on shares of Walgreens Boots Alliance in a research note on Wednesday, March 22nd.
ILLEGAL ACTIVITY NOTICE: "Webster Bank N.A. Buys 235 Shares of Walgreens Boots Alliance, Inc". The stock has an average rating of "Buy" and a consensus price target of $90.62. A 2 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of LZB or, if they already own its stock, sell it. (WBA)'s shares projecting a $93.5 target price. Vanguard Group Inc. boosted its stake in shares of Walgreens Boots Alliance by 5.2% in the first quarter. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & global trademark & copyright law. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/06/23/walgreens-boots-alliance-inc-wba-shares-sold-by-tyers-asset-management-llc-updated.html. The Company is a pharmacy-led health and wellbeing company. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.